Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology
(HEARTBEAT Trial)
Recruiting in Palo Alto (17 mi)
+2 other locations
Overseen ByNassir Marrouche, MD
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Tulane University
No Placebo Group
Trial Summary
What is the purpose of this trial?This is a phase 0, non-interventional, longitudinal, electronic data capture (EDC) study to facilitate the HEARTBEAT Study project has set out to explore the potential use of smartwatches in collecting and analyzing biometric data to improve the detection, identification, and understanding of cardiovascular diseases and related conditions by SAMSUNG and Tulane. The study will include up to ten thousand adult subjects tasked with wearing a smartwatch to collect digital biomarker data over a 1 year period. Concurrent to smartwatch data collection, subjects will be instructed to complete questionnaires via the Huma Decentralized Clinical Trials (HUMADCT) platform. There are no investigational drugs or interventions administered as part of this study.
Eligibility Criteria
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Healthy armExperimental Treatment1 Intervention
Patients visiting a primary care provider for any reason without any cardiovascular diseases, 500 subjects.
Group II: Cohort armExperimental Treatment1 Intervention
Patients with at least one cardiovascular disease, 9500 subjects.
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
East Jefferson General HospitalNew Orleans, LA
Tulane University Medical Group ClinicsNew Orleans, LA
University Medical CenterNew Orleans, LA
Loading ...
Who is running the clinical trial?
Tulane UniversityLead Sponsor
Samsung ElectronicsIndustry Sponsor